1. PMO-158 RS12979860 CC genotype is associated with baseline high numbers of CD56bright NK-cells, low numbers of CD3-CD56-CD16+ cells, low IL-10 HCV-specific production in CH-C therapy responders. (28th May 2012) Authors: Carey, I; Bruce, M J; Joshi, D; Vergani, D; Agarwal, K Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PMO-163 Fibroscan delineates significant fibrosis better than the King's Fibrosis Score, APRI and FIB4 score when correlated to liver biopsy in a large monocentric cohort of hepatitis C patients. (28th May 2012) Authors: See, L-M; Kok, B; Kamparidis, N; Badot, M-A; Hodgson, S; Carey, I; Joshi, D; Heneghan, M; Harrison, P; Agarwal, K Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PMO-157 HBSAG plasma levels decline helps to predict HBEAG loss but is similar in different NUCLEOS(T)IDE analogues regimens. (28th May 2012) Authors: Horner, M; Bruce, M J; Knighton, S; Al-Freah, M; Joshi, D; Hughes, S; Suddle, A; Harrison, P M; Agarwal, K; Carey, I Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PMO-156 Plasma HBsAG levels correlate with liver cccDNA in tolerant children with infancy acquired chronic hepatitis B infection. (28th May 2012) Authors: Carey, I; Zen, Y; Bruce, M J; Horner, M; Bansal, S; Vergani, D; Mieli-Vergani, G Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PMO-155 Low pre-treatment HBsAG plasma levels, on therapy HBsAG levels decline and IP-10 concentrations increase predict response to treatment in tolerant children with chronic hepatitis B. (28th May 2012) Authors: Carey, I; Bruce, M J; Hussain, M; Horner, M; Bansal, S; Vergani, D; Mieli-Vergani, G Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PMO-178 The significance of viral and serological markers in predicting liver disease severity in e-Ag negative hepatitis b virus infection. (28th May 2012) Authors: Audimoolam, V K; Carey, I; Bruce, M; Horner, M; Abid, S; Agarwal, K; Harrison, P Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PTU-107 Defining the low-risk inactive carrier in chronic hepatitis b with qhbsag: do the same rules apply in children and young adults?. (22nd June 2015) Authors: Hansi, N; Gill, US; Banerjee, M; Naik, S; Tong, W; Foster, GR; Carey, I; Kennedy, PT Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PTU-106 Identifying true immune-tolerant disease in children and young adults with chb using quantified hepatitis b surface antigen levels. (22nd June 2015) Authors: Hansi, N; Gill, US; Banerjee, M; Naik, S; Tong, W; Foster, GR; Carey, I; Kennedy, PT Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P57 The IL28B gene SNP rs12979860 CC haplotype, predictor of response to treatment in chronic HCV infection, is associated to high numbers of CD56bright NK cells, low numbers of CD3-CD56-CD16+ NK cells and low HCV-specific IL-10 production. (6th September 2011) Authors: Carey, I; Bruce, M; Mendes, A; Scalori, A; Joshi, D; Agarwal, K; Mieli-Vergani, G; Vergani, D Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P47 De-novo antiviral therapy with nucleos(t)ide analogues in 'real-life' patients with chronic hepatitis B infection: comparison of virological responses between lamivudine + adefovir vs entecavir vs tenofovir therapy. (6th September 2011) Authors: Carey, I; Nguyen DorothyJoe, H; Al-Freah, M; Knighton, S; Bruce, M; Suddle, A; Harrison, P M; Agarwal, K Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗